APGE
Apogee Therapeutics Inc.
$37.96
+$1.43(+3.91%)
10
Overall
--
Value
10
Tech
--
Quality
Market Cap
$2.18B
Volume
530.08K
52W Range
$26.20 - $63.50
Target Price
$97.88
Order:
Income Statement
| Metric | Trend | Chart | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|
| OPERATING EXPENSES | |||||
| Operating Expenses | $30.7M | $93.0M | $216.9M | ||
| Research & Development | $27.8M | $68.4M | $167.9M | ||
| Research Expense | $27.8M | $68.4M | $167.9M | ||
| Selling, General & Administrative | $226.0K | $24.6M | $49.0M | ||
| General & Administrative Expenses | $226.0K | $24.6M | $49.0M | ||
| Salaries & Wages | $2.7M | -- | $23.3M | ||
| Depreciation & Amortization | -- | -- | $189.0K | ||
| Depreciation & Amortization | -- | -- | $189.0K | ||
| Other Operating Expenses | -- | -- | $-2.7M | ||
| OPERATING INCOME | |||||
| Operating income | $-30.7M | $-93.0M | $-216.9M | ||
| EBITDA | -- | $-84.0M | $-194.2M | ||
| NON-OPERATING ITEMS | |||||
| Interest Expense (Non-Operating) | $9.2M | -- | -- | ||
| Intinc | $92.0K | $9.0M | $34.7M | ||
| Net Non-Operating Interest Income/Expense | $-9.1M | $9.0M | $34.7M | ||
| PRE-TAX INCOME | |||||
| EBIT | -- | $-84.0M | $-182.1M | ||
| Pre-Tax Income | $-39.8M | $-84.0M | $-182.1M | ||
| INCOME TAX | |||||
| Tax Provision | -- | -- | $18.0K | ||
| NET INCOME | |||||
| Net Income | $-39.8M | $-84.0M | $-182.1M | ||
| Net Income (Continuing Operations) | $-39.8M | $-84.0M | $-182.1M | ||
| Net Income (Discontinued Operations) | $-39.8M | $-84.0M | $-182.1M | ||
| Net Income (Common Stockholders) | $-39.8M | $-84.0M | $-182.1M | ||
| Normalized Income | -- | $-66.3M | $-180.3M | ||
| TOTALS | |||||
| Total Expenses | $30.7M | $93.0M | $216.9M | ||
| SHARE & EPS DATA | |||||
| Average Shares Outstanding | $2.5M | $25.0M | $55.2M | ||
| Average Shares Outstanding (Diluted) | $2.5M | $25.0M | $55.2M | ||
| Shares Outstanding | $46.1M | $50.7M | $59.5M | ||
| Basic EPS | $-16.16 | $-3.36 | $-3.3 | ||
| Basic EPS (Continuing Operations) | $-16.16 | $-3.36 | $-3.3 | ||
| Diluted EPS | $-16.16 | $-3.36 | $-3.3 | ||
| Diluted EPS (Continuing Operations) | $-16.16 | $-3.36 | $-3.3 | ||
| OTHER METRICS | |||||
| Other Gand A | $226.0K | $24.6M | $49.0M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APGE | $37.96 | +3.9% | 530.08K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Apogee Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW